These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 20925600)

  • 1. Serotonin receptor signaling and regulation via β-arrestins.
    Bohn LM; Schmid CL
    Crit Rev Biochem Mol Biol; 2010 Dec; 45(6):555-66. PubMed ID: 20925600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The atypical antipsychotics clozapine and olanzapine promote down-regulation and display functional selectivity at human 5-HT7 receptors.
    Andressen KW; Manfra O; Brevik CH; Ulsund AH; Vanhoenacker P; Levy FO; Krobert KA
    Br J Pharmacol; 2015 Aug; 172(15):3846-60. PubMed ID: 25884989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serotonin, but not N-methyltryptamines, activates the serotonin 2A receptor via a ß-arrestin2/Src/Akt signaling complex in vivo.
    Schmid CL; Bohn LM
    J Neurosci; 2010 Oct; 30(40):13513-24. PubMed ID: 20926677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PSD-95 is essential for hallucinogen and atypical antipsychotic drug actions at serotonin receptors.
    Abbas AI; Yadav PN; Yao WD; Arbuckle MI; Grant SG; Caron MG; Roth BL
    J Neurosci; 2009 Jun; 29(22):7124-36. PubMed ID: 19494135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endocrine and receptor pharmacology of serotonergic anxiolytics, antipsychotics and antidepressants.
    Levy AD; Van de Kar LD
    Life Sci; 1992; 51(2):83-94. PubMed ID: 1352027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Agonist-directed signaling of the serotonin 2A receptor depends on beta-arrestin-2 interactions in vivo.
    Schmid CL; Raehal KM; Bohn LM
    Proc Natl Acad Sci U S A; 2008 Jan; 105(3):1079-84. PubMed ID: 18195357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of psychoactive tryptamines with biogenic amine transporters and serotonin receptor subtypes.
    Blough BE; Landavazo A; Decker AM; Partilla JS; Baumann MH; Rothman RB
    Psychopharmacology (Berl); 2014 Oct; 231(21):4135-44. PubMed ID: 24800892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Constitutive activity of serotonin 2C receptors at G protein-independent signaling: modulation by RNA editing and antidepressants.
    Labasque M; Meffre J; Carrat G; Becamel C; Bockaert J; Marin P
    Mol Pharmacol; 2010 Nov; 78(5):818-26. PubMed ID: 20699324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antidepressants, beta-arrestins and GRKs: from regulation of signal desensitization to intracellular multifunctional adaptor functions.
    Golan M; Schreiber G; Avissar S
    Curr Pharm Des; 2009; 15(14):1699-708. PubMed ID: 19442183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arylpiperazine agonists of the serotonin 5-HT1A receptor preferentially activate cAMP signaling versus recruitment of β-arrestin-2.
    Stroth N; Niso M; Colabufo NA; Perrone R; Svenningsson P; Lacivita E; Leopoldo M
    Bioorg Med Chem; 2015 Aug; 23(15):4824-4830. PubMed ID: 26081758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paradoxical trafficking and regulation of 5-HT(2A) receptors by agonists and antagonists.
    Gray JA; Roth BL
    Brain Res Bull; 2001 Nov; 56(5):441-51. PubMed ID: 11750789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of functional selectivity through G protein-dependent and -independent signaling pathways at the adrenergic α(2C) receptor.
    Kurko D; Kapui Z; Nagy J; Lendvai B; Kolok S
    Brain Res Bull; 2014 Aug; 107():89-101. PubMed ID: 25080296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. β-Arrestins in the central nervous system.
    Latapy C; Beaulieu JM
    Prog Mol Biol Transl Sci; 2013; 118():267-95. PubMed ID: 23764058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Teaching old receptors new tricks: biasing seven-transmembrane receptors.
    Rajagopal S; Rajagopal K; Lefkowitz RJ
    Nat Rev Drug Discov; 2010 May; 9(5):373-86. PubMed ID: 20431569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blocking them all: beta-arrestins inhibit cellular signaling.
    Lohse MJ; Klenk C
    Mol Cell; 2008 Sep; 31(5):619-21. PubMed ID: 18775321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Desensitization of G protein-coupled receptors and neuronal functions.
    Gainetdinov RR; Premont RT; Bohn LM; Lefkowitz RJ; Caron MG
    Annu Rev Neurosci; 2004; 27():107-44. PubMed ID: 15217328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Affinity of cyamemazine, an anxiolytic antipsychotic drug, for human recombinant dopamine vs. serotonin receptor subtypes.
    Hameg A; Bayle F; Nuss P; Dupuis P; Garay RP; Dib M
    Biochem Pharmacol; 2003 Feb; 65(3):435-40. PubMed ID: 12527336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beta-arrestin biased agonism/antagonism at cardiovascular seven transmembrane-spanning receptors.
    Lymperopoulos A
    Curr Pharm Des; 2012; 18(2):192-8. PubMed ID: 22229558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. β-Arrestin Recruitment and Biased Agonism at Free Fatty Acid Receptor 1.
    Mancini AD; Bertrand G; Vivot K; Carpentier É; Tremblay C; Ghislain J; Bouvier M; Poitout V
    J Biol Chem; 2015 Aug; 290(34):21131-21140. PubMed ID: 26157145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Control of serotonergic function in medial prefrontal cortex by serotonin-2A receptors through a glutamate-dependent mechanism.
    Martín-Ruiz R; Puig MV; Celada P; Shapiro DA; Roth BL; Mengod G; Artigas F
    J Neurosci; 2001 Dec; 21(24):9856-66. PubMed ID: 11739593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.